PRICE T ROWE ASSOCIATES INC /MD/ - TANDEM DIABETES CARE INC ownership

TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 343 filers reported holding TANDEM DIABETES CARE INC in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.5%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of TANDEM DIABETES CARE INC
ValueSharesWeighting
Q3 2023$724
-7.9%
34,816
+8.7%
0.00%
Q2 2023$786
-93.4%
32,029
-89.0%
0.00%
-100.0%
Q1 2023$11,826
-9.4%
291,191
+0.3%
0.00%0.0%
Q4 2022$13,047
-99.9%
290,266
-28.1%
0.00%
-33.3%
Q3 2022$19,330,000
-48.6%
403,945
-36.4%
0.00%
-40.0%
Q2 2022$37,612,000
-48.5%
635,444
+1.2%
0.01%
-28.6%
Q1 2022$72,995,000
-22.3%
627,697
+0.6%
0.01%
-12.5%
Q4 2021$93,896,000
+20.9%
623,811
-4.1%
0.01%
+14.3%
Q3 2021$77,633,000
+2.0%
650,305
-16.8%
0.01%0.0%
Q2 2021$76,103,000
-21.2%
781,343
-28.6%
0.01%
-30.0%
Q1 2021$96,573,000
-26.4%
1,094,315
-20.2%
0.01%
-23.1%
Q4 2020$131,214,000
-13.0%
1,371,380
+3.2%
0.01%
-23.5%
Q3 2020$150,806,000
+42.2%
1,328,688
+23.9%
0.02%
+30.8%
Q2 2020$106,069,000
+234.2%
1,072,275
+117.4%
0.01%
+160.0%
Q1 2020$31,735,000
+107.3%
493,159
+92.0%
0.01%
+150.0%
Q4 2019$15,310,000
-10.9%
256,835
-11.9%
0.00%0.0%
Q3 2019$17,188,000
-0.9%
291,417
+8.4%
0.00%0.0%
Q2 2019$17,350,000
+9.9%
268,911
+8.1%
0.00%0.0%
Q1 2019$15,793,000
+82.9%
248,713
+9.4%
0.00%
+100.0%
Q4 2018$8,634,000
-18.4%
227,390
-7.9%
0.00%
-50.0%
Q3 2018$10,577,000246,8920.00%
Other shareholders
TANDEM DIABETES CARE INC shareholders Q3 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 474,929$22,725,0003.92%
Soleus Capital Management, L.P. 415,200$19,867,0002.70%
First Light Asset Management, LLC 485,620$23,237,0002.35%
Eagle Health Investments LP 196,400$9,398,0002.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 218,049$10,434,0001.66%
EMINENCE CAPITAL, LP 1,590,787$76,119,0001.59%
Brown Capital Management 2,010,230$96,190,0001.35%
Chicago Capital, LLC 479,873$22,962,0001.33%
Intrinsic Edge Capital Management LLC 247,391$11,838,0001.29%
Bellevue Group AG 1,566,015$74,933,0001.08%
View complete list of TANDEM DIABETES CARE INC shareholders